Cas:19245-25-1 Phenyl phenylcarbonocyanidimidate manufacturer & supplier

Chemical Name:Phenyl phenylcarbonocyanidimidate

CAS.NO:19245-25-1

Synonyms:Cyanamid-dicarbonsaeure-diphenylester;Carbonocyanidimidic acid, N-phenyl-, phenyl ester;Phenyl phenylcarbonocyanidimidate

Molecular Formula:C₁₄H₁₀N₂O

Molecular Weight:222.242

HS Code:

Physical and Chemical Properties:

Melting point:155-158ºC(lit.)

Boiling point:340.1±25.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.568

PSA:45.38000

Exact Mass:222.079315

LogP:3.83

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Cyanamid-dicarbonsaeure-diphenylester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenyl phenylcarbonocyanidimidate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenyl phenylcarbonocyanidimidate Use and application,Phenyl phenylcarbonocyanidimidate technical grade,usp/ep/jp grade.

Related News: Dr. Elsie Melsopp, Head of Solids Formulations for Alcami, says the company successfully helped a client overcome an API supply shortage using Quality by Design (QbD) studies to successfully formulate an orphan drug product. 2,4-bis(trifluoromethyl)-5-cyanooxazole manufacturers The review by EMA’s safety committee (PRAC) supported by experts from the Committee for Advanced Therapies (CAT) found that the viral vector was unlikely to be the cause. 1H-Benzotriazole-1-methanamine, 5-methyl-N,N-dioctyl- suppliers The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics. 2-(4-methoxy-benzoylamino)-3-methyl-but-2-enoyl azide vendor & factory Dr. Elsie Melsopp, Head of Solids Formulations for Alcami, says the company successfully helped a client overcome an API supply shortage using Quality by Design (QbD) studies to successfully formulate an orphan drug product. ,The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics.